Tumor Suppressors Status in Cancer Cell Line Encyclopedia

被引:22
|
作者
Sonkin, Dmitriy [1 ]
Hassan, Mehedi [1 ]
Murphy, Denis J. [1 ]
Tatarinova, Tatiana V. [1 ,2 ]
机构
[1] Univ South Wales, Pontypridd CF37 1DL, M Glam, Wales
[2] Univ So Calif, Lab Appl Pharmacokinet, Los Angeles, CA 90089 USA
关键词
Tumor suppressor; Cancer cell line; CCLE; Loss of function; DNA methylation; Epigenetics; DATABASE; GENE; MDM2; MUTATION; PATHWAY; SAMPLES; TP53;
D O I
10.1016/j.molonc.2013.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressors play a major role in the etiology of human cancer, and typically achieve a tumor-promoting effect upon complete functional inactivation. Bi-allelic inactivation of tumor suppressors may occur through genetic mechanisms (such as loss of function mutation, copy number (CN) loss, or loss of heterozygosity (LOH)), epigenetic mechanisms (such as promoter methylation or histone modification), or a combination of the two. We report systematically derived status of 69 known or putative tumor suppressors, across 799 samples of the Cancer Cell Line Encyclopedia. In order to generate such resource we constructed a novel comprehensive computational framework for the assessment of tumor suppressor functional "status". This approach utilizes several orthogonal genomic data types, including mutation data, copy number, LOH and expression. Through correlation with additional data types (compound sensitivity and gene set activity) we show that this integrative method provides a more accurate assessment of tumor suppressor status than can be inferred by expression, copy number, or mutation alone. This approach has the potential for a more realistic assessment of tumor suppressor genes for both basic and translational oncology research. (C) 2013 Federation. of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 50 条
  • [31] CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer
    Lever, Jake
    Zhao, Eric Y.
    Grewal, Jasleen
    Jones, Martin R.
    Jones, Steven J. M.
    NATURE METHODS, 2019, 16 (06) : 505 - +
  • [32] Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer
    Wrzeszczynski, Kazimierz O.
    Varadan, Vinay
    Byrnes, James
    Lum, Elena
    Kamalakaran, Sitharthan
    Levine, Douglas A.
    Dimitrova, Nevenka
    Zhang, Michael Q.
    Lucito, Robert
    PLOS ONE, 2011, 6 (12):
  • [33] Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells
    Forloni, Matteo
    Gupta, Romi
    Nagarajan, Arvindhan
    Sun, Li-Sha
    Dong, Yuying
    Pirazzoli, Valentina
    Toki, Maria
    Wurtz, Anna
    Melnick, Mary Ann
    Kobayashi, Susumu
    Homer, Robert J.
    Rimm, David L.
    Gettinger, Scott J.
    Politi, Katerina
    Dogra, Shaillay Kumar
    Wajapeyee, Narendra
    CELL REPORTS, 2016, 16 (02): : 457 - 471
  • [34] Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer
    Hirotaka Osada
    Takashi Takahashi
    Oncogene, 2002, 21 : 7421 - 7434
  • [35] MicroRNAs Involved in Inflammatory Breast Cancer: Oncogene and Tumor Suppressors with Possible Targets
    Rezaei, Zohreh
    Sadri, Farzad
    DNA AND CELL BIOLOGY, 2021, 40 (03) : 499 - 512
  • [36] The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors
    Henning Stehr
    Seon-Hi J Jang
    José M Duarte
    Christoph Wierling
    Hans Lehrach
    Michael Lappe
    Bodo MH Lange
    Molecular Cancer, 10
  • [37] Interaction of Two Tumor Suppressors: Phosphatase CTDSPL and Rb Protein
    Beniaminov, A. D.
    Krasnov, G. S.
    Dmitriev, A. A.
    Puzanov, G. A.
    Snopok, B. A.
    Senchenko, V. N.
    Kashuba, V. I.
    MOLECULAR BIOLOGY, 2016, 50 (03) : 438 - 441
  • [38] Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer
    Osada, H
    Takahashi, T
    ONCOGENE, 2002, 21 (48) : 7421 - 7434
  • [39] CTDPathSim: Cell line-tumor deconvoluted pathway-based similarity in the context of precision medicine in cancer
    Bose, Banabithi
    Bozdag, Serdar
    ACM-BCB 2020 - 11TH ACM CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, 2020,
  • [40] (de)MYSTification and INGenuity of tumor suppressors
    Saksouk, N.
    Avvakumov, N.
    Cote, J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (7-8) : 1013 - 1018